medigraphic.com
ISSN 2078-7170 (Electronic)

2021, Number 2

<< Back Next >>

CorSalud 2021; 13 (2)

Quality of life of patients with acute coronary syndrome and peripheral artery disease in cardiovascular rehabilitation

Negrín VT, Rodríguez JAE, Fardales RR, Castellano GLA, Meneses JJC, Rabassa López-Callejas MA

Language: Spanish
References: 39
Page: 155-165
PDF size: 484.81 Kb.


ABSTRACT

Introduction: The coexistence of peripheral artery disease in patients with acute coronary syndrome affects health-related quality of life. Cardiac rehabilitation is an effective tool for the treatment of both diseases.
Objective: To assess health-related quality of life according to the EQ-5D questionnaire before and after rehabilitation.
Method: A total of 484 patients discharged from the coronary care unit with a diagnosis of acute coronary syndrome were studied. They were diagnosed with peripheral artery disease by ankle-brachial index test and started cardiac rehabilitation from March the 1st, 2011 to February the 30th, 2018. Their quality of life was assessed using the EQ-5D questionnaire before and after rehabilitation. The Pearson correlation coefficient was employed for quantitative variables and the Wilcoxon nonparametric test was utilized to contrast the hypothesis of equality between two population medians in ordinal and interval variables.
Results: The dimensions assessed by the EQ-5D quality of life questionnaire show a positive correlation between pain-free walking distance and exercise time with the results of the EQ-5D score, thus demonstrating the benefits of rehabilitation.
Conclusions: Cardiac rehabilitation improved the quality of life of patients with peripheral artery disease and acute coronary syndrome.


REFERENCES

  1. Jansen SCP, Hoorweg BBN, Hoeks SE, van denHouten MML, Scheltinga MRM, Teijink JAW, et al. A systematic review and meta-analysis of the effects of supervised exercise therapy on modifiable cardiovascular risk factors in intermittentclaudication. J Vasc Surg. 2019;69(4):1293-308. e2. [DOI]

  2. Kalinin RE, Suchkov IA, Mzhavanadze ND, Pshennikov AS, Ncheĭe AF. Current aspects of performing treadmill test in patients with peripheral artery disease. Angiol Sosud Khir. 2019;25(2): 25-33. [DOI]

  3. Pereira RJ, Cotta RMM, Franceschini SdCC, Ribeiro RdCL, Sampaio RF, Priore SE, et al. Contribuição dos domínios físico, social, psicológico eambiental para a qualidade de vida global de idosos. Rev Psiquiatr Rio Gd Sul. 2006;28(1):27-38. [DOI]

  4. Gardner AW, Waldstein SR, Montgomery PS,Zhao YD. Effect of cognitive status on exerciseperformance and quality of life in patients withsymptomatic peripheral artery disease. J VascSurg. 2016;63(1):98-104. [DOI]

  5. Novakovic M, Jug B, Lenasi H. Clinical impact ofexercise in patients with peripheral arterial disease. Vascular. 2017;25(4):412-22. [DOI]

  6. Badia X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(Supl 1):79-85.

  7. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelinesfor the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acutemyocardial infarction in patients presenting withST-segment elevation of the European Society ofCardiology (ESC). Eur Heart J. 2018;39(2):119-77. [DOI]

  8. Arós F, Boraita A, Alegría E, Alonso AM, BardajíA, Lamiel R, et al. Guías de práctica clínica de laSociedad Española de Cardiología en pruebas deesfuerzo. Rev Esp Cardiol. 2000;53(8):1063-94.

  9. Ades PA. Cardiac rehabilitation and secondaryprevention of coronary heart disease. N Engl JMed. 2001;345(12):892-902. [DOI]

  10. Anderson JL, Halperin JL, Albert NM, Bozkurt B,Brindis RG, Curtis LH, et al. Management of patients with peripheral artery disease (compilationof 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College ofCardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(13):1425-43. [DOI]

  11. Aboyans V, Ricco J-B, Bartelink M-LE, Björck M,Brodmann M, Cohnert T, et al. Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedadarterial periférica, desarrollada en colaboracióncon la European Society for Vascular Surgery(ESVS). Rev Esp Cardiol. 2018;71(2):111. e1-69. [DOI]

  12. Vaidya A, Kleinegris MC, Severens JL, RamaekersBL, Ten Cate-Hoek AJ, Ten Cate H, Joore MA. Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication. J Comp Eff Res. 2018 Jun;7(6):535-548. [DOI]

  13. Schweikert B, Hunger M, Meisinger C, König HH,Gapp O, Holle R. Quality of life several years aftermyocardial infarction: comparing the MONICA/KORA registry to the general population. EurHeart J. 2009;30(4):436-43. [DOI]

  14. Forte EH, Pedroza CE, Graziano FI, Lagos C, Iglesias R. Calidad de vida de los pacientes con infarto de miocardio. Rev Fed Arg Cardiol. 2018;47(4):196-200.

  15. Herdmana M, Badiab X, Berra S. El EuroQol-5D:una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria. Aten Primaria. 2001;28(6):425-9. [DOI]

  16. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. [DOI]

  17. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, IkedaY, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factorsin outpatients with atherothrombosis. JAMA. 2006;295(2):180-9. [DOI]

  18. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-26. [DOI]

  19. Quiles J, Morillas P, Bertomeu V, Mazon P, Cordero A, Soria F, et al. Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acutecoronary syndrome. Int J Cardiol. 2011;151(1):84-8. [DOI]

  20. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ,Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol. 1994;140(5):418-30. [DOI]

  21. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: theFramingham Study. J Am Geriatr Soc. 1985;33(1):13-8. [DOI]

  22. Cauley JA, Kassem AM, Lane NE, Thorson S. Prevalent peripheral arterial disease and inflammatory burden. BMC Geriatr [Internet]. 2016 [citado 20 Mar 2020];16(1):213. Disponible en:https://doi. org/10. 1186/s12877-016-0389-9

  23. Criqui MH, Fronek A, Barrett-Connor E, KlauberMR, Gabriel S, Goodman D. The prevalence ofperipheral arterial disease in a defined population. Circulation. 1985;71(3):510-5. [DOI]

  24. Hooi JD, Kester AD, Stoffers HE, Overdijk MM,van Ree JW, Knottnerus JA. Incidence of and riskfactors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol. 2001;153(7):666-72. [DOI]

  25. Murabito JM, Evans JC, Nieto K, Larson MG, LevyD, Wilson PW. Prevalence and clinical correlatesof peripheral arterial disease in the FraminghamOffspring Study. Am Heart J. 2002;143(6):961-5. [DOI]

  26. de Oliveira DC, Correia A, Nascimento Neto J,Gurgel M, Sarinho FW, Victor EG. Association Between Ankle-Brachial Index and Coronary Lesions Assessed by Coronary Angiography. Cardiol Res. 2015;6(1):216-20. [DOI]

  27. Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, et al. Acute heart failuresyndromes in patients with coronary artery disease early assessment and treatment. J Am CollCardiol. 2009;53(3):254-63. [DOI]

  28. Ward RP, Goonewardena SN, Lammertin G, LangRM. Comparison of the frequency of abnormalcardiac findings by echocardiography in patientswith and without peripheral arterial disease. Am JCardiol. 2007;99(4):499-503. [DOI]

  29. Gardner AW, Parker DE, Montgomery PS, BlevinsSM. Step-monitored home exercise improves ambulation, vascular function, and inflammation insymptomatic patients with peripheral artery disease: a randomized controlled trial. J Am HeartAssoc [Internet]. 2014 [citado 24 Mar 2020];3(5):e001107. Disponible en:https://doi. org/10. 1161/jaha. 114. 001107

  30. Thatipelli MR, Pellikka PA, McBane RD, RookeTW, Rosales GA, Hodge D, et al. Prognostic valueof ankle-brachial index and dobutamine stressechocardiography for cardiovascular morbidityand all-cause mortality in patients with peripheralarterial disease. J Vasc Surg. 2007;46(1):62-70. [DOI]

  31. Arrarás JI. La calidad de vida en el paciente oncológico [Internet]. Repositorio institucional UNEDPamplona [citado 24 Mar 2020]. Disponible en:https://www. bit. ly/2wRwvdC

  32. Wu AW, Jacobson DL, Berzon RA, Revicki DA,van der Horst C, Fichtenbaum CJ, et al. The effectof mode of administration on medical outcomesstudy health ratings and EuroQol scores in AIDS. Qual Life Res. 1997;6(1):3-10. [DOI]

  33. Bosch JL, Hunink MG. Comparison of the HealthUtilities Index Mark 3 (HUI3) and the EuroQol EQ5D in patients treated for intermittent claudication. Qual Life Res. 2000;9(6):591-601. [DOI]

  34. The World Health Organization. Quality of Lifeassessment (WHOQOL): Position paper from theWorld Health Organization. Soc Sci Med. 1995;41(10):1403-9. [DOI]

  35. Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR. Validation of the EQ-5D in patients with a historyof acute coronary syndrome. Curr Med Res Opin. 2005;21(8):1209-16. [DOI]

  36. Aragao JA, Santos RM, Neves OMG, Aragao ICS,Aragao FMS, Mota MIA, et al. Quality of life in patients with peripheral artery disease. J Vasc Bras. 2018;17(2):117-21. [DOI]

  37. Parmenter BJ, Dieberg G, Phipps G, Smart NA. Exercise training for health-related quality of lifein peripheral artery disease: a systematic reviewand meta-analysis. Vasc Med. 2015;20(1):30-40. [DOI]

  38. Saratzis A, Paraskevopoulos I, Patel S, Donati T,Biasi L, Diamantopoulos A, et al. Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis ofRandomized Controlled Trials. JACC CardiovascInterv. 2019;12(12):1125-36. [DOI]

  39. Mazari FA, Carradice D, Rahman MN, Khan JA,Mockford K, Mehta T, et al. An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease. J Vasc Surg. 2010;52(1):77-84. [DOI]




2020     |     www.medigraphic.com